Numans Health Food Holdings Issues Significant Profit Warning for FY2025

Numans Health Food Holdings Company Limited (Stock Code: 2530) has issued a profit warning that is likely to be highly significant for shareholders and potential investors. The company’s board has disclosed, based on a preliminary review of its unaudited consolidated management accounts for the year ended 31 December 2025 (FY2025), that the Group expects to record a profit after tax of not more than approximately RMB6.0 million for FY2025. This represents a dramatic decline from the profit of approximately RMB74.9 million recorded for the year ended 31 December 2024 (FY2024).

Key Points from the Announcement

• Sharp Drop in Profit: The expected profit for FY2025 is less than 10% of the previous year’s profit, signaling a substantial deterioration in the Group’s financial performance.
• Primary Reasons for Profit Decline:
  • Consumption Downturn: The company attributes the decline to a significant drop in revenue, which it links to a general trend of consumption downgrade within the economy of the People’s Republic of China (PRC). This suggests broader macroeconomic challenges and changing consumer behavior are impacting the company’s core business.
  • Increased Competition: There has been heightened competition from DHA products manufactured domestically in the PRC. This increased competition has likely pressured both prices and market share, further hurting revenue and margins.
  • Inventory Impairment: The Group will recognize an impairment loss on inventories of approximately RMB19.3 million. This is a significant one-off item that directly impacts the bottom line.
• Financial Information Is Preliminary: The profit warning is based on unaudited accounts and the latest available information. The final audited results may differ as the company is still in the process of preparing and finalizing its financial statements for FY2025.
• Results Announcement Timing: The company expects to publish its detailed results announcement for FY2025 before the end of April 2026.

Important Information for Shareholders

• Potential Share Price Sensitivity: The sharp decline in profitability, combined with one-off impairment losses and the impacts of macroeconomic headwinds and competition, are all factors that could have a material impact on the company’s share price once fully disclosed to the market.
• Uncertainties Remain: As the results are not yet finalized and have not been reviewed by the audit committee, shareholders should be aware that figures may be subject to adjustments.
• Guidance for Investors: The company has advised shareholders and potential investors to exercise caution when dealing in the Company’s shares until the full results are published and the impact of these challenges is fully understood.

Board Statement

The announcement is signed by Mr. Wang Ping, Chairman of the Board, and lists the current composition of the Board, underscoring the leadership’s direct involvement in addressing and communicating these financial challenges.

Conclusion

The profit warning issued by Numans Health Food Holdings for FY2025 is highly material and price-sensitive. The anticipated sharp drop in profit, driven by macroeconomic challenges, increased competition, and a significant inventory write-down, constitutes a clear red flag for shareholders and investors. All parties are urged to pay close attention to the company’s forthcoming results announcement and consider these risks when making investment decisions.

Disclaimer: The information in this article is based on the company’s profit warning and is intended for informational purposes only. It does not constitute investment advice. Investors should consult the full results announcement and seek professional advice before making any investment decisions. The final audited figures may differ from the preliminary estimates disclosed here.

View NUMANS Historical chart here